, ,
Presentations this author is a contributor to:
Five weeks of resveratrol supplementation has no effect on GLP-1 secretion, gastric emptying, or glycemic control in type 2 diabetes (#375)
2:00 PM
Michelle J Bound
ADEA Poster Viewing One
The glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, inhibits small intestinal motility, flow, transit and absorption of glucose in health and type 2 diabetes: a randomised controlled trial. (#71)
4:15 PM
Chinmay S Marathe
ADS Clinical Orals: Gut and Glycaemia
A low-dose whey protein preload slows gastric emptying and improves post-prandial glycaemia in type 2 diabetes (#69)
3:45 PM
Linda E Mignone
ADS Clinical Orals: Gut and Glycaemia